Advertisement
"On behalf of the board of directors and management team, I would like tothank Mr. Mo for his many contributions and dedicated service to the Company.His leadership and vision have been invaluable to the Company and we wish himwell in his future endeavors," said Charles Wan, Chief Executive Officer ofBenda Pharmaceutical. "Meanwhile, the Board is conducting a thoroughreplacement search."
Advertisement
About Benda Pharmaceutical, Inc.
Benda Pharmaceutical, Inc. ( http://www.bendapharma.com ), a China-basedpharmaceutical company, produces traditional Chinese and conventionalmedicines, as well as Gendicine(R), a commercialized gene therapy medicine forthe treatment of cancer.
Safe Harbor Statement
The information contained herein includes forward-looking statements.These statements relate to future events or to our future financialperformance, and involve known and unknown risks, uncertainties and otherfactors that may cause our actual results, levels of activity, performance, orachievements to be materially different from any future results, levels ofactivity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-lookingstatements since they involve known and unknown risks, uncertainties and otherfactors which are, in some cases, beyond our control and which could, andlikely will, materially affect actual results, levels of activity, performanceor achievements. Any forward-looking statement reflects our current views withrespect to future events and is subject to these and other risks,uncertainties and assumptions relating to our operations, results ofoperations, growth strategy and liquidity. We assume no obligation to publiclyupdate or revise these forward-looking statements for any reason, or to updatethe reasons actual results could differ materially from those anticipated inthese forward-looking statements, even if new information becomes available inthe future. The safe harbor for forward-looking statements contained in theSecurities Litigation Reform Act of 1995 protects companies from liability fortheir forward-looking statements if they comply with the requirements of theAct.
SOURCE Benda Pharmaceutical, Inc.
